Why This Heart Drug Could Be a $5B Blockbuster for Novartis Post author:Sam Post published:January 23, 2018 Post category:BioPharma Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year. Source: BioSpace You Might Also Like AstraZeneca PLC Confirms CEO is Staying Put—For Now July 16, 2017 NightstaRx Appoints As Chief Development Officer August 1, 2017 Johnson & Johnson Innovation, Releases Impact Report October 11, 2017